IDRA Stock Idera is a biopharmaceutical company focused on rare diseases. Its pipeline includes several promising drugs, including the Phase 2 clinical trial of IMO-8400, a potential treatment for Dermatomyositis. This rare autoimmune disease causes joint pain, muscle weakness and skin rashes. Another drug, GSO-APOC-III, is a potential treatment for Familial Chylomicronemia Syndrome, a rare genetic ...